Denmark's Leo Pharma is pushing its IPO plans past 2026 on market volatility
CEO Christophe Bourdon said Leo Pharma's owners see market conditions as unsuitable and declined to give a new timeline
We haven't written up this one. Quartz has the full story — the link below goes straight to it.